Compare Archer Aviation Inc (ACHR) vs Amphastar Pharmaceuticals Inc (AMPH) Price & Performance

Archer Aviation (ACHR) trades at $5.59, up 6.88% today, with a bullish technical signal from moving averages. The company reported a Q2 2026 loss of $0.34 per share, missing estimates, but revenue trends show growth from $300,000 in 2025 to $2 million in 2026. Recent news highlights a transformative deal with Boeing to acquire Wisk Aero, Insitu, and SkyGrid, expanding into autonomous aviation and defense, which spurred a stock surge and high options trading activity.

The outlook is optimistic due to strategic expansion and strong analyst support, with 78% buy ratings and a 78.7% upside price target. However, risks include persistent losses, negative cash flow from operations, and execution challenges in scaling new businesses, requiring careful monitoring of profitability milestones.

AMPH trades at $20.78, up 4.9% today, with a bullish technical signal supported by moving averages. The stock shows mixed earnings performance with Q2 2026 beating estimates but Q1 and Q4 2025 missing. Fundamentals remain solid with a 10.76% net margin and reasonable valuation at 12.02 P/E. Recent news highlights Q2 2026 results and strategic shift toward proprietary drugs.

Outlook is cautiously optimistic with growth supported by new product launches, though regulatory risks and earnings volatility pose challenges. Analyst sentiment is mixed with 25% buy ratings but majority hold recommendations. The stock offers value but requires monitoring of FDA developments and earnings consistency.